Transcriptomics

Dataset Information

0

Bioinformatic analysis of the mechanism by which metformin enhances chemosensitivity of head and neck squamous cell carcinoma cells


ABSTRACT: Metformin is one of the first-line drugs for clinical treatment of type II diabetes, and recent studies have found that metformin can inhibit the development of multiple malignant tumors. When metformin is combined with chemotherapeutic drugs to treat head and neck squamous cell carcinoma(HNSCC), it can effectively enhance the efficacy of chemotherapy. The aim of this study was to define the signaling pathways regulated by metformin in HNSCC, and the underlying mechanisms by which metformin sensitizes HNSCC chemotherapy. We used RNA sequencing (RNA-seq) to examine metformin regulated genes in the cal27, human tongue squamous carcinoma cell line, using RT-PCR to determine alterations in gene expression. Data from RNA-seq analysis showed that gene products involved in DNA replication, cell cycle, IL-17 signaling pathway, mismatch repair were all regulated by metformin. Our results suggest that metformin regulates multiple pathways associated with tumor growth and progression in HNSCC.

ORGANISM(S): Homo sapiens

PROVIDER: GSE207122 | GEO | 2022/07/03

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2016-08-16 | E-GEOD-85607 | biostudies-arrayexpress
2016-08-16 | GSE85607 | GEO
2016-08-16 | E-GEOD-85608 | biostudies-arrayexpress
2020-11-12 | PXD020159 | Pride
2022-02-16 | PXD028810 | Pride
2016-08-16 | GSE85608 | GEO
2024-01-01 | GSE245159 | GEO
2016-05-17 | GSE70301 | GEO
2018-09-19 | PXD009241 | Pride
2016-10-25 | E-MTAB-4854 | biostudies-arrayexpress